We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
-5.19%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$586M
AUM Growth
+$27.7M
(+5%)
Cap. Flow
+$76.8M
Cap. Flow
% of AUM
13.1%
Top 10 Holdings %
Top 10 Hldgs %
4.62%
Holding
2,170
New
811
Increased
351
Reduced
336
Closed
665
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$3.33M |
| 2 |
Eli Lilly
LLY
|
+$3.21M |
| 3 |
W.W. Grainger
GWW
|
+$2.81M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$2.81M |
| 5 |
Visa
V
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.68M |
| 2 |
Nasdaq
NDAQ
|
+$2.22M |
| 3 |
Oracle
ORCL
|
+$2.22M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.98M |
| 5 |
Deere & Co
DE
|
+$1.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.51% |
| 2 | Technology | 18.98% |
| 3 | Industrials | 14.56% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Financials | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KVSA
1151
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $125K | 0.02% |
11,722
-467
| -4% | -$4.95K |
|
1152
Arcutis Biotherapeutics
ARQT
$3.55B
| $125K | 0.02% |
+23,460
| New | +$200K |
|
1153
Atossa Therapeutics
ATOS
$24.1M
| $123K | 0.02% |
11,162
+8,536
| +325% | +$124K |
|
1154
Cue Biopharma
CUE
$127M
| $123K | 0.02% |
+1,776
| New | +$173K |
|
1155
Health Catalyst
HCAT
$158M
| $122K | 0.02% |
12,064
-2,975
| -20% | -$35.5K |
|
|
MCW
1156
DELISTED
Mister Car Wash
MCW
| $122K | 0.02% |
+22,134
| New | +$169K |
|
1157
Angi Inc
ANGI
$252M
| $121K | 0.02% |
+6,118
| New | +$175K |
|
1158
LegalZoom.com
LZ
$1.39B
| $120K | 0.02% |
+10,937
| New | +$134K |
|
1159
Gladstone Capital
GLAD
$436M
| $119K | 0.02% |
+6,179
| New | +$128K |
|
1160
Century Aluminum
CENX
$4.35B
| $119K | 0.02% |
16,565
-17,543
| -51% | -$141K |
|
1161
Geron
GERN
$930M
| $118K | 0.02% |
+55,844
| New | +$152K |
|
1162
Clover Health Investments
CLOV
$2.28B
| $118K | 0.02% |
109,371
-161,803
| -60% | -$192K |
|
|
WKME
1163
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $118K | 0.02% |
+12,451
| New | +$112K |
|
1164
Ginkgo Bioworks
DNA
$503M
| $118K | 0.02% |
+1,624
| New | +$130K |
|
1165
Rithm Capital
RITM
$5.46B
| $117K | 0.02% |
+12,595
| New | +$124K |
|
|
ATYR
1166
aTyr Pharma
ATYR
$48.4M
| $117K | 0.02% |
73,894
-96,531
| -57% | -$179K |
|
1167
FuelCell Energy
FCEL
$1.57B
| $117K | 0.02% |
+3,035
| New | +$158K |
|
|
MAGN
1168
Magnera Corp
MAGN
$498M
| $115K | 0.02% |
4,430
+3,449
| +352% | +$115K |
|
|
NXDR
1169
Nextdoor Holdings
NXDR
$877M
| $114K | 0.02% |
62,782
+26,103
| +71% | +$64.6K |
|
1170
DHT Holdings
DHT
$2.99B
| $113K | 0.02% |
+10,994
| New | +$103K |
|
1171
Neuronetics
STIM
$130M
| $113K | 0.02% |
83,479
-28,888
| -26% | -$50.6K |
|
1172
W&T Offshore
WTI
$473M
| $112K | 0.02% |
+25,635
| New | +$106K |
|
1173
Aemetis
AMTX
$104M
| $111K | 0.02% |
+26,695
| New | +$163K |
|
1174
DocGo
DCGO
$62.4M
| $109K | 0.02% |
+20,456
| New | +$166K |
|
1175
Emergent Biosolutions
EBS
$377M
| $107K | 0.02% |
31,462
+17,636
| +128% | +$97.8K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q3 2023 Portfolio in Review
As of Q3 2023, XTX Topco held 2,170 positions worth $586M, up 5% from $558M the previous quarter. Its ten largest holdings account for 4.6% of the portfolio.
XTX Topco deployed $76.8M of net new capital in Q3 2023, opening 811 new positions and adding to 351 existing holdings. Its largest new stake was Idexx Laboratories: 6,687 shares worth $2.92M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Nasdaq, an estimated $2.22M trimmed.
- XTX Topco's largest Q3 2023 buy was Idexx Laboratories: 6,687 shares worth $2.92M.
- XTX Topco added most to Microsoft in Q3 2023, an estimated $2.27M increase.
- XTX Topco's biggest Q3 2023 reduction was Nasdaq, cutting an estimated $2.22M.
- XTX Topco fully exited Boeing in Q3 2023, selling an estimated $2.68M.
- XTX Topco's ten largest holdings make up 4.6% of its $586M portfolio in Q3 2023.
- XTX Topco opened 811 new positions and closed 665 in Q3 2023.
- XTX Topco's portfolio value rose 5% quarter-over-quarter to $586M.
Based on XTX Topco's 13F filing for Q3 2023, filed 13 Nov 2023.